(This article was created in collaboration with Claude AI)
Key Takeaways:
- The Blood Stem Cell Gold Standard. Dr. Leonard Zon explains that blood stem cells are the only stem cells used therapeutically, aside from skin, with thousands of bone marrow transplants performed yearly.
- Manufacturing Hope in a Dish. Scientists can reprogram anyone’s blood or skin cells with four genes, inducing them to behave as embryos, creating cells to develop into any organ.
- Cell Therapy’s Breakthrough Year. Recent trials show remarkable results: Biotech firm Vertex cured diabetes in patients now off insulin, a Parkinson’s patient frozen for 17 years is now skiing and swimming after being treated byBlueRock Therapeutics, and epilepsy patients saw seizures drop from 50 per year to one following treatments from biotherapeutics firm Neurona.
- The Good Cells vs. Bad Cells Battle. Zon’s team discovered “eat me” and “don’t eat me” signals that could allow us to mop up bad stem cells.
- Beware the Wild West. Stem cell tourism can be dangerous, with unregulated clinics delivering unproven treatments causing blindness and other complications.
During the “Do Stem Cells Work Right Now?” session at DOC 2024, Dr. Leonard Zon, the Grousbeck Professor of Pediatric Medicine at Harvard Medical School, wanted to clear up any confusion about stem cells.
“There’s a lot of information out there about stem cells, but there’s also a lot of misinformation,” explained the Harvard hematologist who treats children with blood diseases and cancers.
“These stem cells are amazing,” Zon explained. “They have the ability to renew themselves or to make the entire blood system.” For leukemia patients, he can replace their immune system with matched cells from a sibling — a curative treatment that only needs to be done once.
But Zon’s excitement centered on induced pluripotent stem cells. “I could take anybody’s blood here or a skin cell and reprogram it with four genes to make it think it’s an embryo,” he explained. “This will make every organ of your body.”
The clinical results are striking. Biotech firm Vertex has taken stem cell lines and turned them into pancreatic islet cells that produce insulin, then injected billions of the cells into the liver of diabetes patients. The findings, published in June 2025 in the New England Journal of Medicine, show promising outcomes. “They cure the diabetes, and many of those patients are off of their insulin,” he said.
With Parkinson’s disease, companies like BlueRock Therapeutics turn stem cells into dopamine-producing neurons. One Swedish trial patient had Parkinson’s for 17 years and “was completely frozen,” Zon said. “Now he’s skiing and he’s swimming.”
For temporal lobe epilepsy patients experiencing 50 seizures yearly, treatments from Neurona reduce this “down to one seizure a year.”
Zon’s laboratory focuses on manufacturing blood stem cells by growing them with nurse cells, which feed them growth factors. His team has discovered how the immune system interacts with stem cells through “eat me” and “don’t eat me” signals that could help “mop up the bad stem cells.”
Yet Zon’s optimism comes with caution. He warned the gathering about “stem cell tourism,” citing, by example, a patient he’d heard of who went completely blind after receiving infected stem cells at an unregulated clinic.
The contrast couldn’t be starker. While unregulated clinics promise false hope, legitimate research is delivering real results. “The data is unbelievable for this,” Zon said of the emerging cell therapies. “It’s really working right now.”